Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316040 · ClinicalTrials.gov registry record · NA
Assessing the Impact of an Educational HIV Prevention Intervention in Zambia
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 8,270
- Enrollment target
NCT03316040 is a NA study that has completed, run by Columbia University. The registered enrollment target is 8,270 participants.
The verdict
NCT03316040, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8,270 participants
- Enrollment target
Study Summary
In Zambia, 13% of the 15 to 49 year old population lives with HIV. The highest number of new HIV infections is among young people. To counter the spread of the disease, developmental and governmental actors are increasingly relying on educational behavior change tools. A particularly widely used tool, implemented by the German Development Corporation (henceforth, GIZ), is the so-called "Join-In-Circuit on AIDS, Love Sexuality" (JIC). The tool aims to improve a) HIV and sexual reproductive health knowledge, b) HIV testing uptake, and c) demand for health services. Previous research has investigated the direct effect of the JIC on knowledge about Sexually Transmitted Infections (STIs) as well as self-reported sexual behavior in Zimbabwe, and has found positive effects in both domains. The research project evaluates the JIC in Zambia. The study randomly assigns 170 participating schools to five different JIC treatment arms. The first two arms represent control schools. Here, no JIC will be implemented. The third arm implements the JIC among a random subset of students. The fourth arm implements the JIC among indegree central students. The fifth arm implements the JIC among edge betweeness central students. In each school, the JIC will be implemented in one pre-determined grade. Within each school at least 30 students will be selected. For larger schools, 20 percent of students in the selected grade are selected.
Interventions
- BEHAVIORAL JIC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,270 participants |
| Start Date | 2017-03-16 |
| Est. Completion | 2017-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03316040
The ClinicalTrials.gov registry entry for NCT03316040 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8,270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which JIC is the first listed.
NCT03316040 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03316040 about?
NCT03316040 is a clinical study titled "Assessing the Impact of an Educational HIV Prevention Intervention in Zambia". In Zambia, 13% of the 15 to 49 year old population lives with HIV. The highest number of new HIV infections is among young people. To counter the spread of the disease, developmental and governmental actors are increasingly relying on educational behavior change tools. A particularly widely used too...
What is the current status of trial NCT03316040?
This trial is currently completed. It is a NA study. The enrollment target is 8,270 participants. The study started on 2017-03-16. Estimated completion is 2017-12-02.
What interventions are being tested in trial NCT03316040?
The interventions under investigation include: JIC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03316040?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.